Piramal Pharma Solutions
Anurag Vyas has a strong work experience in the pharmaceutical and market research industry. anurag is currently serving as the Head of Strategic Marketing at Piramal Pharma Solutions. Prior to this, they held various roles at ERIS Lifesciences, starting as a Manager of Market Research in 2014 and progressing to Assistant General Manager, Senior Manager, and General Manager of Market Research and Strategy. In these positions, they focused on analytics, creating actionable insights, defining KPIs, evaluating growth opportunities, generating market intelligence reports, and tracking the impact of marketing campaigns. anurag also managed a high-performing team and provided consulting support to commercial teams. Before joining ERIS Lifesciences, Anurag worked as a Manager of Market Research at Torrent Pharmaceuticals Ltd. anurag began their career at Nielsen as a Senior Client Solutions Executive, where they specialized in account management and business development for global clients in the FMCG industry.
Anurag Vyas has a Master of Business Administration (MBA) degree in Marketing from the Institute of Management, Nirma University. In addition, they obtained a Post Graduate Program in Business Analytics & Business Intelligence, Data Science (PGPBABI) from the Great Lakes Institute of Management in 2020. Anurag also has certifications in "Business Research and Analytics For Effective Decision Making" from MICA | The School of Ideas and "Train the Trainer" from Dale Carnegie Training.
This person is not in the org chart
This person is not in any offices
Piramal Pharma Solutions
3 followers
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.